Norges Bank Neuro Pace Inc Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$7.06 - $11.57 $409,480 - $671,060	58,000 New	58,000 $476,000
Q1 2022 May 09, 2022	SELL	$7.06 - $11.57 $409,480 - $671,060	-58,000 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$8.63 - $17.36 $500,540 - $1.01 Million	58,000 New	58,000 $585,000
Q3 2021 Nov 14, 2022	BUY	$15.85 - $25.07 $919,300 - $1.45 Million	58,000 New	58,000 $919,000
Q3 2021 Nov 05, 2021	SELL	$15.85 - $25.07 $919,300 - $1.45 Million	-58,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$19.03 - $26.5 $1.1 Million - $1.54 Million	58,000 New	58,000 $1.38 Million

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $241M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.